Lataa...

Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and Mesothelin

Liver cancer is one of the most common malignancies worldwide. Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the two most common primary liver cancers, yet there have been no significant advances in effective therapeutics. There is an urgent need to identify molecular targets for t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijä: Ho, Mitchell
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3198870/
https://ncbi.nlm.nih.gov/pubmed/21942912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11595360-000000000-00000
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!